Ectin Research AB, a pharmaceutical company, engages in developing a treatment that eliminates cancer tumors. Its drug candidate MFA-370 that is in Phase I/II clinical trial for the treatment of metastatic urothelial bladder cancer. The company was incorporated in 2013 and is based in Mölndal, Sweden.